Barclays’s Humana HUM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $11.5M | Sell |
66,200
-3,200
| -5% | -$656K | ﹤0.01% | 1382 |
|
|
2025
Q4 | $17.8M | Sell |
69,400
-141,400
| -67% | -$37.1M | ﹤0.01% | 1309 |
|
|
2025
Q3 | $54.8M | Buy |
+210,800
| New | +$55.4M | 0.01% | 725 |
|
|
2025
Q2 | – | Sell |
-335,500
| Closed | -$88.8M | – | 5393 |
|
|
2025
Q1 | $88.8M | Buy |
335,500
+251,200
| +298% | +$67.9M | 0.03% | 460 |
|
|
2024
Q4 | $21.4M | Sell |
84,300
-12,700
| -13% | -$3.41M | 0.01% | 1086 |
|
|
2024
Q3 | $30.7M | Buy |
+97,000
| New | +$34.5M | 0.01% | 859 |
|
|
2024
Q2 | – | Sell |
-26,900
| Closed | -$9.33M | – | 5061 |
|
|
2024
Q1 | $9.33M | Buy |
26,900
+11,800
| +78% | +$4.47M | ﹤0.01% | 1445 |
|
|
2023
Q4 | $6.91M | Buy |
+15,100
| New | +$7.44M | ﹤0.01% | 1825 |
|
|
2023
Q2 | – | Sell |
-26,700
| Closed | -$13M | – | 4766 |
|
|
2023
Q1 | $13M | Buy |
26,700
+300
| +1% | +$148K | 0.01% | 1056 |
|
|
2022
Q4 | $13.5M | Buy |
+26,400
| New | +$13.9M | 0.01% | 1067 |
|
|
2022
Q1 | – | Sell |
-10,600
| Closed | -$4.92M | – | 5248 |
|
|
2021
Q4 | $4.92M | Buy |
10,600
+7,600
| +253% | +$3.36M | ﹤0.01% | 1722 |
|
|
2021
Q3 | $1.17M | Hold |
3,000
| – | – | ﹤0.01% | 2692 |
|
|
2021
Q2 | $1.33M | Hold |
3,000
| – | – | ﹤0.01% | 2473 |
|
|
2021
Q1 | $1.26M | Sell |
3,000
-1,000
| -25% | -$399K | ﹤0.01% | 2630 |
|
|
2020
Q4 | $1.64M | Hold |
4,000
| – | – | ﹤0.01% | 2402 |
|
|
2020
Q3 | $1.66M | Sell |
4,000
-2,100
| -34% | -$845K | ﹤0.01% | 2264 |
|
|
2020
Q2 | $2.37M | Sell |
6,100
-20,500
| -77% | -$7.67M | ﹤0.01% | 1960 |
|
|
2020
Q1 | $8.35M | Sell |
26,600
-11,100
| -29% | -$3.74M | 0.01% | 1106 |
|
|
2019
Q4 | $13.8M | Buy |
37,700
+3,100
| +9% | +$983K | 0.01% | 1180 |
|
|
2019
Q3 | $8.85M | Buy |
34,600
+4,400
| +15% | +$1.23M | 0.01% | 1379 |
|
|
2019
Q2 | $8.01M | Buy |
30,200
+3,800
| +14% | +$964K | ﹤0.01% | 1502 |
|
|
2019
Q1 | $7.02M | Sell |
26,400
-40,700
| -61% | -$11.7M | ﹤0.01% | 1440 |
|
|
2018
Q4 | $19.2M | Buy |
67,100
+6,000
| +10% | +$1.9M | 0.01% | 766 |
|
|
2018
Q3 | $20.7M | Buy |
61,100
+800
| +1% | +$260K | 0.01% | 830 |
|
|
2018
Q2 | $17.9M | Buy |
60,300
+600
| +1% | +$176K | 0.02% | 847 |
|
|
2018
Q1 | $16.1M | Buy |
59,700
+38,800
| +186% | +$10.5M | 0.01% | 958 |
|
|
2017
Q4 | $5.18M | Buy |
20,900
+9,100
| +77% | +$2.25M | ﹤0.01% | 1640 |
|
|
2017
Q3 | $2.88M | Sell |
11,800
-4,400
| -27% | -$1.08M | ﹤0.01% | 1995 |
|
|
2017
Q2 | $3.9M | Sell |
16,200
-796,200
| -98% | -$180M | ﹤0.01% | 1651 |
|
|
2017
Q1 | $167M | Buy |
812,400
+386,700
| +91% | +$79.9M | 0.18% | 83 |
|
|
2016
Q4 | $86.9M | Buy |
425,700
+64,400
| +18% | +$12.3M | 0.09% | 166 |
|
|
2016
Q3 | $63.9M | Buy |
361,300
+327,100
| +956% | +$56.8M | 0.07% | 203 |
|
|
2016
Q2 | $6.15M | Buy |
34,200
+18,300
| +115% | +$3.25M | 0.01% | 1165 |
|
|
2016
Q1 | $2.89M | Sell |
15,900
-185,000
| -92% | -$32.1M | ﹤0.01% | 1620 |
|
|
2015
Q4 | $35.8M | Sell |
200,900
-57,500
| -22% | -$10.1M | 0.04% | 369 |
|
|
2015
Q3 | $46.3M | Sell |
258,400
-355,700
| -58% | -$65.7M | 0.06% | 302 |
|
|
2015
Q2 | $117M | Buy |
614,100
+496,700
| +423% | +$92.2M | 0.13% | 122 |
|
|
2015
Q1 | $20.9M | Sell |
117,400
-456,200
| -80% | -$72.2M | 0.02% | 656 |
|
|
2014
Q4 | $82M | Buy |
573,600
+323,800
| +130% | +$44.2M | 0.08% | 205 |
|
|
2014
Q3 | $32.5M | Buy |
249,800
+3,400
| +1% | +$432K | 0.03% | 497 |
|
|
2014
Q2 | $31.3M | Sell |
246,400
-14,800
| -6% | -$1.75M | 0.03% | 477 |
|
|
2014
Q1 | $29.3M | Sell |
261,200
-195,500
| -43% | -$20.4M | 0.03% | 499 |
|
|
2013
Q4 | $47M | Buy |
456,700
+219,000
| +92% | +$21.5M | 0.05% | 368 |
|
|
2013
Q3 | $22.1M | Buy |
237,700
+143,700
| +153% | +$13.2M | 0.03% | 613 |
|
|
2013
Q2 | $7.93M | Buy |
+94,000
| New | +$7.42M | 0.01% | 1262 |
|
Other funds holding HUM
VCM
VPM
SC
Barclays's HUM Position: Q1 2026 in Review
Barclays increased its Humana (HUM) stake by 13% in Q1 2026, buying an estimated $9.43M and bringing the position to 399,577 shares worth $69.3M. The position accounts for 0.02% of the portfolio, ranked #623.
Barclays first reported a position in HUM in Q2 2013 and has held it in 52 quarters since. The position peaked at $163M in Q4 2023. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.
- Barclays held 399,577 shares of Humana worth $69.3M as of Q1 2026.
- Barclays bought 45,998 Humana shares in Q1 2026, an estimated $9.43M.
- Humana made up 0.02% of Barclays's portfolio in Q1 2026, its #623 holding.
- Barclays first reported a position in Humana in Q2 2013 and has held it in 52 quarters since.
- Barclays's Humana position peaked at $163M in Q4 2023.
- 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.